Page 107 - Annual Report 2021
P. 107

30. Financial instruMEnts (cOnt’D)
              30.1  CATEGORIES OF FINANCIAL INSTRUMENTS


                                                               the group                     the company
                                                          2021             2020          2021           2020
                                                           rM             rM              rM             rM

                  Financial liabilities


                  Amortised Cost
                    Trade payables (Note 20)            18,876,045      17,537,153            -              -
                  Other payables and accruals (Note 21)    25,507,369   16,497,108     8,236,946      2,659,548
                  Amount owing to holding entity (Note 13)    32,295,267    32,669,582    14,998,171    16,691,129
                  Amount owing to related parties (Note 15)   5,198,978    6,664,524          -              -
                                                        81,877,659     73,368,367      23,235,117    19,350,677


              30.2  FAIR VALUE INFORMATION
                   The methods used in determining the fair values of financial instruments recognised on the statements of financial
                   position are disclosed in their respective notes to the financial statements.


           31.  signiFicant EVEnts During tHE Financial YEar
              The World Health Organisation (“WHO”) declared the 2019 Novel Coronavirus infection (“COVID- 19”) a global
              pandemic on 11 March 2020. The Government of Malaysia had imposed the Movement Control Order (“MCO”) on
              18 March 2020. The MCO was subsequently extended with different phases enacted nationwide. On 15 June 2021,
              the Government further introduced the National Re- covery Plan (“NRP”) to help the country to emerge from the
              COVID-19 pandemic while continuing to control the spread of the infection.




































                                                                                                Annual Report 2021      107
   102   103   104   105   106   107   108   109   110